Tilray/$TLRY
14:30
16:10
17:45
19:25
21:00
1D1W1MYTD1Y5YMAX
About Tilray
Tilray is a Canadian producer that cultivates and sells medical and recreational cannabis. In 2021, legacy Aphria acquired legacy Tilray in a reverse merger and renamed itself Tilray. The bulk of its sales are in Canada and in the international medical cannabis export market. US exposure comes mostly from alcohol.
Ticker
$TLRY
Sector
Primary listing
Employees
2,842
Headquarters
Leamington, Canada
Website
Tilray Metrics
BasicAdvanced
$1.4B
-
-$2.30
2.13
-
Price and volume
Market cap
$1.4B
Beta
2.13
52-week high
$2.32
52-week low
$0.35
Average daily volume
94M
Financial strength
Current ratio
2.62
Quick ratio
1.39
Long term debt to equity
19.188
Total debt to equity
21.29
Interest coverage (TTM)
-2.31%
Profitability
EBITDA (TTM)
28.871
Gross margin (TTM)
28.86%
Net profit margin (TTM)
-258.54%
Operating margin (TTM)
-10.64%
Effective tax rate (TTM)
5.47%
Revenue per employee (TTM)
$290,000
Management effectiveness
Return on assets (TTM)
-1.74%
Return on equity (TTM)
-85.74%
Valuation
Price to revenue (TTM)
1.398
Price to book
0.9
Price to tangible book (TTM)
1.81
Price to free cash flow (TTM)
-11.931
Free cash flow yield (TTM)
-8.38%
Free cash flow per share (TTM)
-0.104
Growth
Revenue change (TTM)
2.31%
Earnings per share change (TTM)
753.77%
3-year revenue growth (CAGR)
10.63%
10-year revenue growth (CAGR)
94.12%
3-year earnings per share growth (CAGR)
32.17%
10-year earnings per share growth (CAGR)
39.70%
What the Analysts think about Tilray
Analyst ratings (Buy, Hold, Sell) for Tilray stock.
Bulls say / Bears say
Tilray achieved record fiscal year 2025 net revenue of $821.3 million, a 4% year-over-year increase driven by diversified growth across its beverage, cannabis, and wellness segments (GlobeNewswire)
Global cannabis gross margin expanded by approximately 700 basis points to 40% in FY2025, reflecting the company’s strategic focus on higher-margin products and SKU rationalization (GlobeNewswire)
Tilray reduced total debt by nearly $100 million during FY2025, improving its net debt-to-EBITDA ratio to 0.3× and ending the year with $256 million in cash and marketable securities, strengthening its balance sheet for future investments (GlobeNewswire)
The company reported a GAAP net loss of $1.27 billion in Q4 FY2025, driven by a $1.4 billion non-cash impairment charge related to goodwill and intangible assets, raising concerns about the valuation of its acquisitions (Investing.com)
Net revenue for Q4 FY2025 fell to $224.5 million from $229.9 million a year earlier, as strategic SKU rationalization and unexpected international permit delays trimmed $35 million of sales, indicating near-term headwinds from operational streamlining (GlobeNewswire)
Valuations for major cannabis players, including Tilray, have plummeted amid industry oversupply, heavy regulation, and stalled legalization, with combined market caps down from $37 billion in 2021 to $4 billion in 2025, undermining long-term growth optimism (Reuters)
Data summarised monthly by Lightyear AI. Last updated on 6 Nov 2025.
Tilray Financial Performance
Revenues and expenses
Tilray Earnings Performance
Company profitability
Tilray News
AllArticlesVideos
Top Canadian Cannabis Stocks to Watch in November 2025
MarijuanaStocks6 days ago
'Trump effect' raises hopes for cannabis rally as investors bet on federal reforms, softer marijuana stance
CNBC1 week ago
Canadian Cannabis Leaders Poised for Growth as U.S. Legalization Momentum Builds
MarijuanaStocks3 weeks ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Tilray stock?
Tilray (TLRY) has a market cap of $1.4B as of November 10, 2025.
What is the P/E ratio for Tilray stock?
The price to earnings (P/E) ratio for Tilray (TLRY) stock is 0 as of November 10, 2025.
Does Tilray stock pay dividends?
No, Tilray (TLRY) stock does not pay dividends to its shareholders as of November 10, 2025.
When is the next Tilray dividend payment date?
Tilray (TLRY) stock does not pay dividends to its shareholders.
What is the beta indicator for Tilray?
Tilray (TLRY) has a beta rating of 2.13. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.